Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Certain factors may increase susceptibility to burping and related gastrointestinal symptoms, including: Rapid dose escalation (not following the recommended titration schedule) Concurrent use of other medications affecting gut motility (such as opioids or anticholinergics) Pre-existing gastrointestinal conditions such as gastroparesis or gastroesophageal reflux disease (GERD) Dietary habits that promote gas production Gastrointestinal adverse effects, including burping, are generally more common and pronounced at higher doses, which explains the higher rates observed with Wegovy compared to Ozempic
and (vi) work with employer and health plan clients to increase affordability and predictability
It is waiting for the right signal to calm the storm
According to clinical trials, adults with type 2 diabetes taking the highest dose of tirzepatide (15 mg) achieved an A1C reduction of 2.46 percent and a weight loss of about 13 percent over 40 weeks
